Difference between cystatin C- and creatinine-based estimated glomerular filtration rate and incident hypertension and the mediating role of Triglyceride Glucose Index

基于胱抑素C和肌酐的估算肾小球滤过率与新发高血压之间的差异以及甘油三酯葡萄糖指数的中介作用

阅读:1

Abstract

Estimated glomerular filtration rate (eGFR) is usually calculated based on serum creatinine (eGFR(Scr)) or cystatin C (eGFR(CysC)). This study aimed to investigate the association between cystatin C-creatinine eGFR discordance (ΔeGFR(CysC-Scr)) and new-onset hypertension and to assess the mediating role of triglyceride glucose (TyG) index based on the China Health and Retirement Longitudinal Study. The ΔeGFR(CysC-Scr) was calculated by eGFR(CysC) - eGFR(Scr). A Cox proportional risk model was used to assess the association between ΔeGFR(CysC-Scr) and risk of new-onset hypertension. The mediating role of TyG was assessed using mediation analysis, and thresholds were obtained via Receiver Operating Characteristic curve. A total of 4,644 participants (median age 59 years, 55.5% female) were finally included. During a mean follow-up period of 5.0 years, 613 new cases of hypertension occurred. Multivariable analysis showed that, individuals in negative-ΔeGFR(CysC-Scr) group (< -15) had a 24% increase risk of hypertension (Hazard ratio [HR] = 1.24; 95% confidence interval [95% CI]: 0.99, 1.56), while positive-ΔeGFR(CysC-Scr) group (≥15) had a 20% decrease risk of hypertension (HR = 0.80; 95% CI: 0.63, 1.02), compared with those in the reference group (-15 ≤ ΔeGFR(CysC-Scr) < 15 mL/min/1.73 m(2)). In addition, each 15 mL/min/1.73m(2) increase in ΔeGFR(CysC-Scr) was associated with a 13.4% reduction in the risk of new-onset hypertension (HR= 0.87; 95% CI: 0.79, 0.95). TyG acted as a partial mediator, explaining 9.3% of the total effect. The present study demonstrates an association between ΔeGFR(CysC-Scr) and the risk of new-onset hypertension and reveals the important mediating role of TyG in this association.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。